Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
TC Energy Corp
TRP
5
Power Corporation of Canada
POW
CA Stock MarketDetailed Quotes
NVS Novartis AG
- 21.680
- +0.250+1.17%
15min DelayTrading Apr 24 11:30 ET
286.92BMarket Cap17.21P/E (TTM)
21.680High21.680Low747Volume21.680Open21.430Pre Close16.19KTurnover23.49852wk High0.00%Turnover Ratio13.23BShares20.11052wk Low1.26EPS TTM39.14BFloat Cap23.498Historical High17.21P/E (Static)1.81BShs Float20.110Historical Low1.26EPS LYR0.00%Amplitude--Dividend TTM4.70P/B1Lot Size--Div YieldTTM
About Novartis AG Company
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
Company Profile
SymbolNVS
Company NameNovartis AG
Founded1996
MarketNEOE
Employees75883
Fiscal Year Ends12-31
AddressLichtstrasse 35
CityBasel
CountrySwitzerland
Zip Code4056
Phone+41 613241111
Websitehttps://www.novartis.com
Company Executives
- Name
- Position
- Salary
- Dr. Vasant Narasimhan
- Chief Executive Officer
- 14.19M
- Karen L. Hale
- Chief Legal Officer
- --
- Robert Kowalski
- Chief People and Organization Officer
- --
- Harry Kirsch
- Chief Financial Officer
- 6.27M
- Dr. Shreeram Aradhye, M.D.
- President, Development and Chief Medical Officer
- --
- Dr. Klaus Moosmayer, PhD
- Chief Ethics, Risk and Compliance Officer
- --
- Dr. Aharon Gal, PhD
- Chief Strategy and Growth Officer
- --
- Victor Bulto
- President, US
- 5.77M
- Simon E Moroney, D.Phil.
- Vice Chairman of the Board
- 460.00K
- Joerg Reinhardt, PhD
- Chairman of the Board
- 3.80M
- Dr. Steffen Lang, PhD
- President, Operations
- --
- Dr. Patrick Horber, M.D.
- President, International
- 5.89M
- Dr. Fiona H. Marshall, PhD
- President, Biomedical Research
- --
- Elizabeth Doherty
- Independent Director
- 450.00K
- Bridgette P. Heller
- Independent Director
- 430.00K
- Ana de Pro Gonzalo
- Independent Director
- 390.00K
- William Thomas Winters
- Independent Director
- 360.00K
- Ton Buechner
- Independent Director
- 424.68K
- Patrice Bula
- Lead Independent Director
- 413.78K
- John Douglas Young
- Independent Director
- 385.00K
- Frans Van Houten
- Independent Director
- 390.00K
- Daniel Hochstrasser
- Independent Director
- 394.68K
- Dr. Nancy C. Andrews, M.D.,PhD
- Independent Director
- 360.00K
- Dr. Charles L. Sawyers
- Independent Director
- 360.00K
Market Insights
Dividend Kings of Canada Dividend Kings of Canada
Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.
Unlock Now
Big Five Big Five
The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.
Unlock Now